Remittance Advice Alerts/PROMISe Banner Pages
Banner Date: March 29, 2019 through April 16, 2019
Cycles: 40, 41, 42
Provider Types: 07, 08, 09, 24, 31
Subject: Revisions to Participating Drug Company list for Medicaid Drug Rebate Program
 
Subject: Revisions to Participating Drug Company list for Medicaid Drug Rebate Program
 
For a drug product to be compensable through the Medical Assistance (MA) Program, the company (labeler) that markets the product must participate in the Federal Medicaid Drug Rebate Program.
 
The below revisions to the list, unless otherwise indicated, are effective April 1, 2019. Terminations and additions apply only to those National Drug Codes (NDCs) beginning with the five-digit labeler code indicated, and not to other NDCs that may be marketed by that company under a different labeler code.
 
NEW and REINSTATED LABELERS
CATALYST PHARMACEUTICALS, INC. (69616)
STEMLINE THERAPEUTICS, INC. (72187)
MILLICENT U.S., INC. (72495)
NOVIMMUNE S.A. (72171)
EYEPOINT PHARMACEUTICALS US, INC. (71879)
TITAN PHARMACEUTICALS, INC. (52440)
ANALOG PHARMA, INC. (70505)
COHERUS BIOSCIENCES, INC. (70114)
KALA PHARMACEUTICALS, INC. (71571)
ASEGUA THERAPEUTICS LLC (72626)
BLUE EARTH DIAGNOSTICS (69932)
IBSA PHARMA, INC. (71858)
LOXO ONCOLOGY, INC. (71777)
AQUESTIVE THERAPEUTICS, INC. (10094)
MYLAN CONSUMER HEALTHCARE, INC. (46017)
REPHARM LLC (61145)
 
TERMINATED LABELERS, MANDATORY AND VOLUNTARY
IRONWOOD PHARMACEUTICALS, INC. (70785)
APNAR PHARMA LP (24689)
BRANDYWINE PHARMACEUTICALS, LLC (71321)
ROCHESTER PHARMACEUTICALS (49908)
 
Back to RA Banner List